← Leaderboards
Stephen A Bernard
University Of North Carolina Chapel Hill
$27,273
Attributed
$27,273
Total exposure
2
Grants
2
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $9.4K · FY2005–07$10K$7.5K$5K$2.5K$0
'05
'06
'07
Funding mix
By agency
NIH$27,273 · 2
By mechanism
M01$27,273 · 2
Top collaborators
No co-investigators on record.
Most similar at University Of North Carolina Chapel Hill
Same institution · by research overlap
- Thomas Shea$5,623,497
- Stephen J Bernard$0
- Linmarie Sikich$18,880,212
- Mathew J Ewend$0
- Kimberly Ann Brownley$1,665,885
Others in their field
Top investigators on “Tamoxifen”
- Norman Wolmark · Nsabp Foundation, Inc.$79,931,398
- Charles A Coltman · Southwest Oncology Group$64,630,528
- Laurence H Baker · University Of Michigan At Ann Arbor$22,633,578
- David Alastair Flockhart · Georgetown University$17,768,070
- Gary K Owens · University Of Virginia$14,826,758
- John L Bryant · University Of Pittsburgh At Pittsburgh$12,247,088
Research focus
TamoxifenRaloxifeneBreast NeoplasmsCancer PreventionCancer RiskClinical ResearchComputer Retrieval Of Information On Scientific Projects DatabaseDrug Adverse EffectDrug Screening /EvaluationEstrogen InhibitorFemaleFundingGrantHuman SubjectHuman Therapy EvaluationIncidenceInstitutionMalignant Neoplasm Of BreastMalignant NeoplasmsNamesNoltamOptrumaPatient Oriented ResearchPurpose
Grant awards (4)
STUDY OF TAMOXIFEN AND RALOXIFENE (STAR) FOR THE PREVENTION OF BREAST CANCER$1,501
M01 · FY2007 · RR · contact PI
STUDY OF TAMOXIFEN AND RALOXIFENE (STAR) FOR THE PREVENTION OF BREAST CANCER$4,460
M01 · FY2006 · RR · contact PI
STUDY OF TAMOXIFEN AND RALOXIFENE (STAR) FOR THE PREVENTION OF BREAST CANCER$9,425
M01 · FY2005 · RR
Study of Tamoxifen and Raloxifene (STAR) for the Prevention of Breast Cancer$11,887
M01 · FY2004 · RR